NAD Supplement Guide: How to Pick a Form, Find Your Dose, and Judge Whether It's Working

Start at 250 mg of NMN or NR once daily in the morning, hold it two weeks, then judge the product at four to six weeks. Every NAD supplement sold is a precursor, not NAD+ itself. These products reliably raise blood NAD+. No human trial shows they extend life.

TL;DR: Key takeaways

• You cannot buy NAD+. You buy NMN, NR, or nicotinamide, and your cells rebuild NAD+ from them.
• 250 to 500 mg a day covers most people. Above 1,000 mg a day buys unknowns, not benefit.
• Morning dose, empty stomach if tolerated, and a hard decision point at four to six weeks.
• Third-party certification (NSF, USP, ConsumerLab) matters more than which precursor you choose.
• Short-term tolerability is good. Multi-year safety data does not exist yet.

An NAD supplement doesn't contain NAD+, and that's the point

Every NAD supplement on the shelf is a precursor product. You buy NMN, NR, or plain nicotinamide, start at 250 mg once daily in the morning, hold that dose for two weeks, and reassess at four to six weeks. NAD+ itself is not the ingredient, because the intact molecule cannot cross a cell membrane, so your cells rebuild it from whatever precursor you swallowed.

That membrane problem is the core fact of the category, and Jinfiniti's dosing guidance makes it explicitly: swallowed or infused NAD+ gets broken down to precursors before any cell can use it. Delivery format changes how much precursor arrives, not what happens next. Goldman Laboratories puts standard oral absorption at roughly 10 to 20 percent and liposomal formats near 60 percent, figures worth treating as vendor estimates rather than settled pharmacology.

Three precursor families, plainly: NMN, NR, and the old vitamin B3 forms, nicotinamide (niacinamide) and niacin. The usual rationale for taking any of them is a roughly 50 percent decline in NAD+ between ages 20 and 50, a number Goldman Laboratories and most of the industry cite.

NAD+ benefits show up on blood tests, not yet in lifespans

The documented NAD+ benefits stop at the blood test. A 2022 review of human NAD+ boosting trials found that NR and NMN consistently raise blood and cellular NAD+ and are generally well tolerated over weeks to months, and that no human study has shown they extend lifespan, reduce mortality, or treat an age-related disease.

The animal data is less flattering than the marketing implies. In a 2018 mouse study, nicotinamide improved healthspan markers (less fatty liver, better glucose clearance, less oxidative damage) but did not extend maximum lifespan.

Here is what most pages will not tell you: when you read about NAD+ benefits in product copy, the evidence underneath is almost always cell culture or rodents, and the rodent experiment closest to the longevity claim did not produce longevity.

So the verdict is narrow and useful. Treat an NAD supplement as an unproven metabolic-support product, not the longevity drug the category is sold as.

Step 1: Pick your precursor by who you are, not by which one is newest

The NMN vs NR question is really a question about you, not about the molecules. Goldman Laboratories frames NMN as distributing through the whole body and NR as more liver weighted, a reasonable working model that no human trial has confirmed as clinically meaningful. What is genuinely established is the paper trail: NR has been commercialized longest and carries the deepest human dosing data, including placebo-controlled trials. NMN has its own randomized, double-blind, placebo-controlled dose-ranging trial in healthy middle-aged adults, which found it well tolerated with no safety signal on adverse-event monitoring or lab testing.

Decide by profile. If cost is the binding constraint, buy nicotinamide, the cheapest route into the same pathway. For general use over 50, an NMN supplement or NR at 250 to 500 mg a day is the mainstream choice. If your interest is metabolic or liver health, NR at 300 mg a day has the most human data behind it. If your interest is skin, nicotinamide.

No head-to-head human trial has established one precursor as superior. Let profile and price decide, not novelty.

Step 2: Start at 250 mg and climb only if you have a reason to

NAD+ dosage is where the category's "more is better" instinct does the most damage. In a placebo-controlled trial of nicotinamide riboside, 100, 300, and 1,000 mg a day raised whole-blood NAD+ by 22 percent, 51 percent, and 142 percent within two weeks, with no significant difference in adverse events versus placebo. Read that curve carefully. The blood number keeps climbing. Nothing in the trial shows the extra climb does anything for you.

Jinfiniti names an intracellular target of roughly 40 to 100 μM. Translated into something you can act on: most people land in that range on about 250 to 500 mg a day of NMN or NR. Above roughly 1,000 mg a day there is no established added benefit and a longer list of unknowns.

A workable NAD+ dosage ladder looks like this. Take 150 to 250 mg a day for two weeks. If you tolerate it and have a specific reason to go higher, move to 300 to 500 mg a day. If flushing, nausea, or headache appear, step back down to the last dose that felt fine and stay there.

The ceilings are reassuring as far as they go. Oregon State's Linus Pauling Institute summarizes trials in which NR was tolerated up to 2,000 mg a day for 12 weeks in adults with obesity, with only minor sweating and mild gastrointestinal symptoms, and in which 250 to 500 mg a day showed a favorable safety profile in adults aged 60 to 80.

One number not to misread: the Tolerable Upper Intake Level for niacin is 35 mg a day for adults, set specifically to avoid flushing. That applies to the vitamin B3 forms. It is not a ceiling for NR or NMN, which have no federal upper limit.

Step 3: Take it in the morning, and give it six weeks before you judge it

Take your dose in the morning, ideally on an empty stomach about 30 minutes before food. If that reliably makes you queasy, take it with food and accept slightly slower absorption, which is a better trade than quitting. Splitting into an AM and PM dose is only worth the bother above about 500 mg a day, and late-evening dosing has no established advantage.

Then set the deadline nobody else gives you. Four to six weeks on a steady dose, then decide: continue, adjust, or stop. "Give it time" is how people spend two years on a supplement they never evaluated.

Before day one, name one or two outcomes you can actually track. Afternoon energy, recovery after hard exercise, sleep quality. Write them down with a number each day, because memory will quietly confirm whatever you spent the money on. A health companion app like August AI can help you log your dose and how you feel day to day, as an adjunct to your own judgment and your clinician's, never as the thing deciding your dose.

Stacking is fine. If you already take a nightly magnesium supplement, keeping it at bedtime and the precursor at breakfast keeps the two from muddying each other's side-effect profile.

Step 3 continued: if there is no third-party seal, assume the dose on the label is wrong

The NMN supplement market has a label problem, and Goldman Laboratories cites batch-testing data showing products that overstate how much active ingredient they actually contain. In a category where your whole plan is a milligram number, an uncertified 500 mg capsule is not a dose. It is a guess.

Look for NSF Certified for Sport, USP Verified, or ConsumerLab testing on the specific product, not on the brand's reputation. If a product has no third-party testing at all, buy a different product. Do not raise the dose to compensate for a label you already decided you cannot trust, which is the same label-trust trap that surrounds hair-growth supplements like Nutrafol.

And treat any "proprietary blend" that does not state milligrams per precursor as unusable. You cannot titrate what you cannot count.

IV NAD+ drips are a convenience purchase, not a stronger dose

Jinfiniti puts IV sessions at $300 to $800 each, against a month of oral precursor at a small fraction of that. Goldman Laboratories' own numbers undercut the premium: near-100 percent systemic delivery, but only about a 2 percent rise in blood NAD+ at 24 hours. The resolution is the membrane fact from the top of this page. Because NAD+ cannot enter cells intact, infused NAD+ is degraded into the same precursors a capsule supplies. IV is a convenience and marketing choice, not a superiority one.

NAD supplement side effects are mostly mild, and the unknowns are the real issue

The common NAD supplement side effects are dose-related and dull: flushing, nausea, headache, and mild gastrointestinal upset, plus the sweating reported at 2,000 mg a day of NR. Flushing is mostly a niacin phenomenon. The Linus Pauling Institute notes it can occur with nicotinic acid at doses as low as 30 mg a day, while it is rare with nicotinamide.

The catch: short-term tolerability is not the open question. The 2022 uncertainties review flags three things that are genuinely unresolved, namely possible worsening of glucose intolerance, a potential pro-tumor effect in people with advanced cancer, and accumulation of the breakdown metabolites 2-PY and MeNAM, whose long-term effects nobody has characterized. The same review is blunt that no multi-year human safety trials of NR or NMN exist. Human data covers weeks to a few months, and people take these products for years.

If a reaction is bothersome but clearly not an emergency, a persistent headache or nausea that has not settled after you reduced the dose, August's $39 online urgent care visit can get a US-licensed clinician to review your symptoms and your supplement list. The clinician decides whether any treatment or prescription is appropriate. That visit cannot draw in-person labs, examine you physically, or manage an emergency.

When to stop the supplement and when to ask first

Call 911 or go to an emergency room now if:

• You develop facial or throat swelling, hives, or trouble breathing after a dose or an infusion.
• You have chest pain, a pounding or irregular heartbeat, a severe headache, or fainting during or after an IV NAD+ infusion.
• Your skin or eyes turn yellow, your urine darkens, or you have severe pain in the upper right abdomen.
• Flushing comes with dizziness, a racing heart, or fainting, rather than ordinary mild warmth.

Book a visit within the next week if:

• Nausea or headache persists even after you cut the dose back.
• Your home glucose readings drift upward after starting a precursor.
• Unexplained fatigue or a new rash continues on a steady dose.

Talk to a clinician before you start if:

• You have current or past cancer. Get your oncologist's input first, given the unresolved pro-tumor signals.
• You are pregnant or breastfeeding.
• You have kidney or liver impairment.
• You take diabetes medication, a statin, or an anticoagulant.

If you are not sure which tier you are in, the free August AI Symptom Checker will walk you through triage questions in a few minutes and point you toward the right level of care.

The bottom line

Buy a third-party-certified NMN or NR product, start at 250 mg each morning, hold two weeks, and consider 300 to 500 mg only if you tolerated it and have a reason. Track one or two outcomes and decide at four to six weeks. An NAD supplement is a reasonable, low-risk experiment in metabolic support, not a proven way to age more slowly.

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions. If you are experiencing a medical emergency, call 911 or go to the nearest emergency room immediately.